- Home
- CDE vs SNN Comparison
CDE vs SNN Comparison
Compare CDE & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CDE | SNN |
|---|---|---|
| Founded | 1928 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Precious Metals | Industrial Specialties |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 14.3B |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | CDE | SNN |
|---|---|---|
| Price | $22.28 | $36.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $21.50 | ★ $32.83 |
| AVG Volume (30 Days) | ★ 29.7M | 951.7K |
| Earning Date | 02-18-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 2.06% |
| EPS Growth | N/A | ★ 59.91 |
| EPS | ★ 0.74 | 0.56 |
| Revenue | $1,700,723,000.00 | ★ $5,944,000,000.00 |
| Revenue This Year | $96.49 | $7.71 |
| Revenue Next Year | $43.51 | $5.23 |
| P/E Ratio | ★ $28.37 | $30.80 |
| Revenue Growth | ★ 68.28 | 5.35 |
| 52 Week Low | $4.58 | $23.91 |
| 52 Week High | $27.77 | $38.79 |
Technical Indicators
Market Signals| Indicator | CDE | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 49.37 | 66.68 |
| Support Level | $20.91 | $34.20 |
| Resistance Level | $23.71 | $35.50 |
| Average True Range (ATR) | 1.75 | 0.61 |
| MACD | -0.30 | 0.20 |
| Stochastic Oscillator | 30.97 | 96.51 |
Price Performance
Historical ComparisonAbout CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.